ArticleEuropean urology2010
Words of wisdom. Re: overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer.
Ellen A M SchenkPubMed ↗Publisher ↗
No numbers read from the abstract.